Daily Judi: Tuesday, December 27, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Vox looks at nine scientific advances of 2022, including vaccine development, deterring the spread of mpox, and psychedelic research.
In a study of multiple myeloma clinical trials in North Carolina, the rate of poverty appears associated with the likelihood a county would have a clinical trial site. (Helio)
NPR's Morning Edition discusses the advances and limitations of a blood test that can screen for multiple cancers—a focus of President Biden's Cancer Moonshot initiative.
Our Culture
“Dossiers and redaction are built within the Judi platform, which helps significantly with adjudication management—and the client collaborates on the process.”
–Jess, Program Manager
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
